01 December 2007
Piezosurgery in the excision of middle-ear tumors: effects on mineralized and non-mineralized tissues
Angelo SalamiB, Massimo DellepianeA, Francesco Antonio SalzanoF, Renzo MoraEMed Sci Monit 2007; 13(12): PI25-29 :: ID: 563740
Abstract
Background
Piezosurgery is a new instrument able to cut bone without necrosis and non-mineralized tissue damage. The aim of this study was to test the Piezosurgery as a new and alternative method for the excision of middle-ear tumors and to analyze its effects on soft tissues.
Material and Method
The Piezosurgery device was used to excise eight glomus tympanicum tumors and two primary B-cell lymphomas of the middle ear. The piezoelectric device uses low-frequency ultrasonic waves (24.7-29.5 kHz); the applied power can be modulated between 2.8 and 16 W and is programmed in accordance to the density of the bone. The equipment consists of two hand-pieces, two inserts, and two peristaltic pumps. The microvibrations that are created in the piezoelectric hand-piece cause the inserts to vibrate linearly by between 60 and 210 microm.
Results
Piezosurgery provided excellent control in all the patients, without bleeding and harmful effects on the adjacent structures of the middle and inner ear.
Conclusions
Piezosurgery is a new and revolutionary osteotomy technique utilizing the microvibrations of scalpels at ultrasonic frequency, so that soft tissue will not be damaged even upon accidental contact with the cutting tip. The vibration frequency of Piezosurgery is optimal for mineralized tissue and does not cut the adjacent soft tissue, minimizing the risk of harming the adjacent tissues. This renders the piezoelectric device ideal for application at the border between hard and soft tissues as in the excision of a middle-ear tumor.
Keywords: Lymphoma, B-Cell - surgery, Glomus Tympanicum Tumor - surgery, Osteotomy, Ear, Middle - surgery, Ear Neoplasms - surgery
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952